Floatz logo

Therapeutic Asset Ratings

176 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Autologous Cd5/Cd7 Dual-Target Car-T Module
T-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (45)
Autologous Cd5/Cd7 Dual-Target Car-T Module
Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm
Beijing BiotechP1/2CC (45)
Autologous Cd5/Cd7 Dual-Target Car-T Module
T-Lymphoblastic Lymphoma
Beijing BiotechP1/2CC (45)
CD56 CAR-NK cells
Small Cell Lung Carcinoma
Beijing BiotechP1/2CC (45)
Cyclophosphamide
Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm
Beijing BiotechP1/2CC (45)
Dual-Target Car-Nk Cell Product
Primary Peritoneal Carcinoma
Beijing BiotechP1/2CC (45)
Dual-Target Car-Nk Cells
Triple-Negative Breast Carcinoma
Beijing BiotechP1/2CC (45)
Eb-Car30-Nk
Thymic Carcinoma
Beijing BiotechP1/2CC (45)
Eb-Car5-Nk
Thymic Carcinoma
Beijing BiotechP1/2CC (45)
Eb-Carmsln-Nk
Thymic Carcinoma
Beijing BiotechP1/2CC (45)
Eb-Dart-Nk01
Small Cell Lung Carcinoma
Beijing BiotechP1/2CC (45)
Eb-Dtkn-401 Allogeneic Dual-Target Cspg4/Gd2 Car-Nk Cells
Uveal Melanoma
Beijing BiotechP1/2CC (45)
Eb-Duo-Car-Nk-Cea/Gcc
Colorectal Adenocarcinoma
Beijing BiotechP1/2CC (45)
Eb-G3B7-Nk Dual-Target Car-Nk Cells
Hepatocellular Carcinoma
Beijing BiotechP1/2CC (45)
Fludarabine
Relapsed/Refractory Acute Myeloid Leukemia, High-risk Myelodysplastic Neoplasm
Beijing BiotechP1/2CC (45)
Rimiducid
Cortical Thymoma
Beijing BiotechP1/2CC (45)
Cyclophosphamide
Renal Pelvis/Ureter Urothelial Carcinoma
Beijing BiotechP1CC (43)
Dual-Target Car-Nk Cells
Malignant Glioma
Beijing BiotechP1CC (43)
Eb-Dt-Nk-Uc101
Renal Pelvis/Ureter Urothelial Carcinoma
Beijing BiotechP1CC (43)
Etb-Dualnk-01
Prostate Adenocarcinoma
Beijing BiotechP1CC (43)
Etb-Dualnk-01
Prostate Cancer
Beijing BiotechP1CC (43)
Etb-Dualnk-01
Castration-Resistant Prostate Carcinoma
Beijing BiotechP1CC (43)
Fludarabine
Renal Pelvis/Ureter Urothelial Carcinoma
Beijing BiotechP1CC (43)
Autologous Bcma/Cd19 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Autologous Bcma/Cd38 Dual-Target Car-T Module
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Beijing BiotechP1/2CC (43)
Showing 126 to 150 of 176 assets
PreviousPage 6 of 8Next